Cibisatamab selectively induced specific lysis in the CEAhigh-expressing MKN-45 cancer spheroids, as well as milder specific lysis in rectal organoids with intermediate CEA expression, while sparing the small intestinal organoids and the DLD-1 spheroids, both of which had low CEA levels (Figure 4E). This evidence concerns the gene CEACAM5 and cancer.